Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Tight Blood Glucose Control Within Normal Fasting Ranges With Insulin Titration Prescribed by the Leuven Algorithm in Adult Critically Ill Patients

NCT03665207 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT03665207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Tight Blood Glucose Control Within Normal Fasting Ranges With Insulin Titration Prescribed by the Leuven Algorithm in Adult Critically Ill Patients
Lead sponsor
KU Leuven
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 18, 2018
Completion date
November 30, 2026
Enrollment
9,230 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, hyperglycemia